tiprankstipranks
Trending News
More News >
COSMO Pharmaceuticals N.V. (CH:COPN)
:COPN
Switzerland Market

COSMO Pharmaceuticals N.V. (COPN) Income Statement

Compare
16 Followers

COSMO Pharmaceuticals N.V. Income Statement

Last quarter (Q2 2025), COSMO Pharmaceuticals N.V.'s total revenue was €51.72M, an increase of 18.46% from the same quarter last year. In Q2, COSMO Pharmaceuticals N.V.'s net income was €-2.01M. See COSMO Pharmaceuticals N.V.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
€ 266.79M€ 92.78M€ 102.09M€ 65.07M€ 60.95M
Gross Profit
€ 246.92M€ 53.44M€ 83.33M€ 49.93M€ 50.51M
Operating Expenses
€ 98.04M€ 47.29M€ 55.27M€ 21.00M€ 26.43M
Depreciation and Amortization
€ 12.29M€ 13.55M€ 13.11M€ 6.71M€ 6.04M
EBITDA
€ 165.71M€ 19.70M€ 46.74M€ 17.81M€ 7.84M
Operating Income
€ 148.88M€ 6.15M€ 28.06M€ 11.10M€ 6.91M
Other Income/Expenses
€ 4.49M€ -4.61M€ -3.58M€ 12.90M€ -13.84M
Pretax Income
€ 153.37M€ 1.53M€ 24.47M€ 24.00M€ -6.93M
Net Income
€ 133.24M€ -4.93M€ 17.23M€ 21.67M€ -7.90M
Per Share Metrics
Basic EPS
€ 8.15€ -0.31€ 1.05€ 1.29€ -0.55
Diluted EPS
€ 8.12€ -0.31€ 1.05€ 1.28€ -0.55
Weighted Average Shares Outstanding
16.36M 16.11M 16.43M 16.84M 14.47M
Weighted Average Shares Outstanding (Diluted)
16.42M 16.11M 16.43M 16.90M 14.47M
Currency in EUR

COSMO Pharmaceuticals N.V. Earnings and Revenue History